Opportunity Information: Apply for RFA HG 20 047

This funding opportunity, titled "Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed)" (RFA HG 20 047), is an NIH discretionary grant mechanism offered as a cooperative agreement (U01). Its central aim is to support Predictive Modeling and Analysis Projects that create and apply new computational approaches to forecast how genomic variation changes genome function and/or observable outcomes such as molecular or organism-level phenotypes. The emphasis is on building innovative models that help translate DNA-level differences into functional consequences, ultimately improving understanding of how genetic variation contributes to human health and disease. Because it is a "Clinical Trial Not Allowed" opportunity, proposed work should not be designed as a clinical trial; instead, it should focus on computational modeling, analysis, and related research activities that do not meet the NIH definition of a clinical trial.

A key feature of this FOA is that funded projects will not operate in isolation. Awardees will become part of the Impact of Genomic Variation on Function Consortium, meaning each project is expected to collaborate actively with other consortium members and related components. Practically, that consortium participation implies coordinated planning around data collection strategies, shared analytical approaches where appropriate, and a general commitment to working together to speed progress on common scientific goals. The cooperative agreement structure also signals that NIH will likely have substantial programmatic involvement compared with a typical investigator-initiated grant, with an expectation of coordination, communication, and shared milestones across the consortium.

The scientific scope centers on predicting the functional impact of genomic variation. That can include models that interpret variants in coding regions, noncoding regulatory regions, structural variants, or other types of genetic changes, as long as the work advances the ability to predict how variation affects genome function or phenotype. The FOA description highlights innovation in computational models, which often includes statistical modeling, machine learning, integrative multi-omics approaches, and methods that leverage large-scale functional genomics resources. While the opportunity text is brief, the consortium framing strongly suggests applicants should plan for interoperability with community data standards, reproducibility, and collaborative data-sharing practices that make their predictions comparable and useful across projects.

Eligibility is broad and includes many types of domestic applicants: state, county, and local governments; special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other organizations. The FOA explicitly calls out additional eligible applicant categories as well, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, Indian/Native American tribal governments other than federally recognized entities, and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility is consistent with a consortium model that benefits from varied institutional strengths, including academic, nonprofit, governmental, and international partners.

Administratively, the opportunity is run under the NIH with an activity category in health and a CFDA number of 93.172. The original posting dates in the provided source data indicate a creation date of 2020-08-03 and an original closing date of 2020-11-04. The excerpted fields do not provide an award ceiling or expected number of awards, so applicants would normally look to the full FOA for budget guidance, project period limits, and the anticipated scale of the program. Overall, the opportunity is best understood as support for computational, collaborative, consortium-based research that improves the ability to predict what genetic variants do, connecting genomic differences to functional outcomes in a way that can accelerate progress in human genetics and disease research.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
  • This funding opportunity was created on 2020-08-03.
  • Applicants must submit their applications by 2020-11-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA HG 20 047

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Previous opportunity: Notice of Funding Opportunity

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HG 20 047

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HG 20 047) also looked into and applied for these:

Funding Opportunity
Systematic Characterization of Genomic Variation on Genomic Function and Phenotype (UM1 Clinical Trial Not Allowed) Apply for RFA HG 20 043

Funding Number: RFA HG 20 043
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) Apply for PAR 20 286

Funding Number: PAR 20 286
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed) Apply for RFA NS 21 006

Funding Number: RFA NS 21 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed) Apply for PAR 20 270

Funding Number: PAR 20 270
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) Apply for RFA TR 20 003

Funding Number: RFA TR 20 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) Apply for PAR 20 263

Funding Number: PAR 20 263
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 20 264

Funding Number: PAR 20 264
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) Apply for RFA MH 20 600

Funding Number: RFA MH 20 600
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 21 020

Funding Number: RFA AG 21 020
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 21 021

Funding Number: RFA AG 21 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed) Apply for RFA NS 21 007

Funding Number: RFA NS 21 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) Apply for PAR 20 259

Funding Number: PAR 20 259
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support Apply for PA 20 074

Funding Number: PA 20 074
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $1,000,000
Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) Apply for PAR 20 258

Funding Number: PAR 20 258
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA TR 20 030

Funding Number: RFA TR 20 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes (U01 Clinical Trial Not Allowed) Apply for RFA HL 21 015

Funding Number: RFA HL 21 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 21 024

Funding Number: PAR 21 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed) Apply for RFA EY 20 001

Funding Number: RFA EY 20 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) Apply for PAR 20 293

Funding Number: PAR 20 293
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed) Apply for PAR 20 296

Funding Number: PAR 20 296
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 20 047", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: